|
| 36349721 | Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms. | Br J Haematol | 2023 |
| 36349721 | Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms. | Br J Haematol | 2023 |
| 33300245 | Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants. | Hum Mutat | 2021 |
| 33446413 | Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data. | Clin Breast Cancer | 2021 |
| 33300245 | Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants. | Hum Mutat | 2021 |
| 33446413 | Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data. | Clin Breast Cancer | 2021 |
| 32196822 | Damaging de novo missense variants in EEF1A2 lead to a developmental and degenerative epileptic-dyskinetic encephalopathy. | Hum Mutat | 2020 |
| 32196822 | Damaging de novo missense variants in EEF1A2 lead to a developmental and degenerative epileptic-dyskinetic encephalopathy. | Hum Mutat | 2020 |
| 32108894 | Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens. | JAMA Netw Open | 2020 |
| 32108894 | Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens. | JAMA Netw Open | 2020 |
| 30608580 | Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the protein. | Hum Mol Genet | 2019 |
| 31570899 | Integrated genomic profiling expands clinical options for patients with cancer. | Nat Biotechnol | 2019 |
| 30608580 | Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the protein. | Hum Mol Genet | 2019 |
| 30128536 | Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing. | JAMA Oncol | 2019 |
| 31040929 | Clinical validation of the tempus xT next-generation targeted oncology sequencing assay. | Oncotarget | 2019 |
| 30128536 | Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing. | JAMA Oncol | 2019 |
| 31570899 | Integrated genomic profiling expands clinical options for patients with cancer. | Nat Biotechnol | 2019 |
| 31040929 | Clinical validation of the tempus xT next-generation targeted oncology sequencing assay. | Oncotarget | 2019 |
| 28881385 | Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance. | Clin Genet | 2018 |
| 28881385 | Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance. | Clin Genet | 2018 |
| 30311380 | Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. | Hum Mutat | 2018 |
| 29899824 | Clinical validation of the Tempus xO assay. | Oncotarget | 2018 |
| 29489755 | Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. | Nature | 2018 |
| 29388939 | Correction: Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. | Genet Med | 2018 |
| 29251763 | De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms. | Clin Genet | 2018 |
| 29899824 | Clinical validation of the Tempus xO assay. | Oncotarget | 2018 |
| 30311380 | Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. | Hum Mutat | 2018 |
| 29388939 | Correction: Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. | Genet Med | 2018 |
| 29489755 | Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. | Nature | 2018 |
| 29251763 | De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms. | Clin Genet | 2018 |
| 27513193 | Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. | Genet Med | 2017 |
| 28418444 | Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. | JAMA Oncol | 2017 |
| 28667181 | <i>DNM1</i> encephalopathy: A new disease of vesicle fission. | Neurology | 2017 |
| 27513193 | Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. | Genet Med | 2017 |
| 27598823 | Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features. | Clin Genet | 2017 |
| 28418444 | Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. | JAMA Oncol | 2017 |
| 28667181 | <i>DNM1</i> encephalopathy: A new disease of vesicle fission. | Neurology | 2017 |
| 27598823 | Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features. | Clin Genet | 2017 |
| 27543892 | A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia. | Ann Neurol | 2016 |
| 27352968 | Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy. | Eur J Hum Genet | 2016 |
| 27798625 | The genomic landscape of core-binding factor acute myeloid leukemias. | Nat Genet | 2016 |
| 27822389 | Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes. | Int J Breast Cancer | 2016 |
| 27543892 | A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia. | Ann Neurol | 2016 |
| 27822389 | Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes. | Int J Breast Cancer | 2016 |
| 27798625 | The genomic landscape of core-binding factor acute myeloid leukemias. | Nat Genet | 2016 |
| 27352968 | Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy. | Eur J Hum Genet | 2016 |
| 25730765 | The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. | Nat Genet | 2015 |
| 25730765 | The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. | Nat Genet | 2015 |
| 25855603 | PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia. | Blood | 2015 |
| 27081547 | Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia. | Hum Genome Var | 2015 |